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binding and the behavior of proteins at the membrane channels are areas that will probably receive substan-
tial attention in the near future. Specifically regardingsurface. Many signal transduction events occur at the
cell membrane. For a few well-characterized examples chemical sensors, there are several challenges that
must be solved in order to make channel-based sen-such as Ras and Src, we know that a combination of
electrostatic interactions and lipid modifications influ- sors useful as an industrial technology [3]. First, they
must be made more physically robust so that they areence signaling at the membrane [6]. However, there is
a growing body of evidence that suggests that the ac- able to withstand the passage of large volumes of ana-
lytes over time. Second, channel-based sensors needtivity of other membrane-associated signaling proteins,
including protein kinases, are influenced by voltage to be scaled-up to true multiplex systems to allow for
greater throughput. If these technical hurdles can bechanges at the membrane [7, 8]. At first glance, the
voltage-dependent differences in stochastic sensing of overcome, then engineered ion channels will likely be
directed toward an enormous number of chemicalthe interactions between tethered PKIP and PKAc ap-
pear to be an unexplained quirky feature of the mea- sensing applications.
surement. Perhaps these unexpected results may lead
to powerful new studies to examine the voltage-depen- Todd C. Holmes
dent behavior of proteins kinases and other important Department of Biology
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gress in ion channel engineering, a new field which has
two major branches. One is devoted to in vivo/thera-
Selected Readingpeutic applications and the other to sensor technology.
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Riboswitch Structures: Purine
Ligands Replace Tertiary Contacts
CTwo recent reports describe the fascinating crystal
cstructures of the G-riboswitch complexed to three dif-
sferent purine ligands, hypoxanthine [1], guanine, and
fadenine [2].
b
iA riboswitch is a natural RNA biosensor that, in the
npresence of a specific metabolite, changes conforma-
ttion, thereby controlling cellular metabolism [3]. Two
new studies report three X-ray riboswitch structures: cwo of the guanine-responsive riboswitch complexed
ith hypoxanthine at 1.95 Å [1] and guanine at 2.4 Å
2]. The third structure, solved at 2.1 Å resolution [2], is
hat of the related A-sensing mRNA, in which a single
to U mutation renders the RNA switch adenine spe-
ific [4]. In each complex, the RNA has essentially the
ame length—from 67 to 71 nt. The fold of the RNA
ragment is amazingly compact, with a great number of
eautifully intricate tertiary interactions. The metabolite
s, in each case, sandwiched within a cavity between 4
ucleotides to which it makes specific H bonding con-
acts. The 5#-UTR of the controlled mRNA exists in a
onformational equilibrium between states with or
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11without a transcription terminator helix. The metabolite
alters the state of the equilibrium. Interestingly, the
similarly bound complexes promote the formation of
the terminator helix in the G-riboswitch, thus inactiva-
ting transcription, whereas in the A-riboswitch the com-
plex promotes the formation of the antiterminator helix
and thus activates transcription [4, 5]. Therefore, posi-
tive or negative effects on biological activity can be
achieved by the relative position of the riboswitch with
respect to neighboring sequences.
Elegantly, Batey and coworkers [1] solved the crystal-
lographic phase problem of the G-riboswitch by using
single wavelength anomalous diffraction data on co-
balt, while Serganov and coworkers used the anoma-
lous properties of barium for solving the A-riboswitch
[2]. The RNA folds are all very similar and, independent
of the biological impact of riboswitches recently re-
viewed [5–7], deserve special focus. Here we will re-
strict the discussion to the high-resolution G-riboswitch
structure complexed with hypoxanthine [1].
At the secondary structure level, the riboswitch forms
a three-way junction (Figure 1). This type of junction is
frequent in secondary structure diagrams of structured
RNAs. For example, ribosomal RNA structures contain
several three-way junctions, and a celebrated one is
that constituting the L11 protein binding site [8]. The
SRP RNA contains two three-way junctions in the Alu
and the S domains [9, 10]. With the recent availability
of crystallographic structures, some general rules
about the folding of RNA three-way junctions start to
emerge.Figure 1. Schematic Drawing of a Three-Way Junction
Schematic drawing of a three-way junction: starting from the 5#
end, Watson-Crick paired stems are numbered P1, P2, P3, with the
junctions between them numbered J12, J23, J31 and the capping
loops L2 and L3, respectively [2]. When the length of J23 is longer
than the other two junction lengths, coaxial stacking between P3
and P1 often occurs (indicated by the continuous double arrows)
generally with, depending on the relative lengths of stems P2 and
P3 and the fold of J23, loop-loop interactions between the apical
loops L2 and L3 (indicated by the dashed double arrows). In such
a case, J23 forms a “pseudo-loop” closed by a pair. In the ribo-
switch, J12, J23, J31 have, respectively, 3, 8, and 2 nucleotides. In
the hammerhead ribozymes, the lengths are 2, 7, and 4. For the Alu
[9] and S [10] domains of the SRP RNA, as well as for the L11 rRNA
fragment [8], J12 and J23 are either 0 or 1 with J23 between 4 and
6 nucleotides.In multiple helical junctions, the choice of coaxial or
contiguous stacking of helices is one of the main struc-
tural determinants. The junction strands J12, J23, and
J31 are rarely of the same length, with one junction
strand typically being longer than the other two. In such
a case, the coaxial stacking generally occurs opposite
to that longer junction strand. Thus, as illustrated in
Figure 1, with J23 longer than J12 and J31, helices P3
and P1 will form a contiguous stack. Further, depending
on the fold of J23 and the relative lengths of helices P2
and P3, loop-loop interactions between L2 and L3 can
form. In all the examples cited above, such loop-loop
interactions do occur. The diversity and complexity of
those loop-loop tertiary contacts depend on the length
of the loops and are astonishing. For example, in the
Alu domain of the SRP RNA, the loop-loop contacts are
essentially made via Watson-Crick pairs [9] while, in the
S-domain of the SRP RNA where L2 (capping helix 6)
and L3 (capping helix 8) are generally tetraloops, the
interactions are made of two consecutive symmetric
trans pairs involving either the Watson-Crick sites or
the sugar-edge sites [10].
The loop-loop interactions in the riboswitch are do-
minated by two standard Watson-Crick G=C pairs link-
ing the 3# and 5# ends of loops L2 and L3, respectively
(Figure 2). The sugar-edges of three of the bases in-
volved in the Watson-Crick pairs interact with neigh-
boring adenines, two of which in L3 forming trans
Hoogsteen/Watson-Crick pairs with bases of L2. An-
other striking structural feature is the intercalation of an
adenine of L2 into L3 forming a trans Hoogsteen/Wat-
son-Crick pair below an apical GU platform.
The fold of J23 is a key structural determinant in
three-way junctions. In several instances, the first and
last residues form a pair, cis Watson-Crick in the ribo-
switch and transWatson-Crick in the L11 rRNA [8] (Fig-
ure 3). In two cases (L11 rRNA and the S domain of
SRP RNA), the second residue of the “pseudo-loop”
forms a U-turn with the next two adjacent adenines in-
volved in A-minor contacts [11, 12] to the last two con-
secutive canonical Watson-Crick base pairs of P1.
Interestingly, in the riboswitch, two adjacent pyrimi-
dines of J23, following a bulging U and not a U-turn,
form cis Watson-Crick/sugar-edge pairs with the last
two consecutive canonical Watson-Crick base pairs of
P1. These interactions constitute a much less frequent
minor groove interaction. They all occur within an in-
ternal loop, not between distinct RNA elements, and
are akin to C motifs [13] (Figure 2). The purine binding
site is situated next to those two minor groove con-
tacts, in between J23 and P1, with the Watson-Crick
edges of two facing pyrimidines interacting, respec-
tively, with the Watson-Crick and sugar-edge of the pu-
rine cofactor (Figure 2). In addition, a standard Watson-
Crick base pair links the first residue of J12 with the
penultimate residue of J23 and stacks upon the purine
cofactor. Finally, the second residue of J12 is engaged
in a Watson-Crick/sugar-edge pair with the Watson-
Crick pair capping the “pseudo-loop” formed by J23.
The purine cofactor, therefore, glues together the P1
helix to the J23 junction and prevents the 3# strand of
the P1 helix to disengage itself and to form alternative
structures. The structural comparisons (Figure 2) sug-
gest that the purine cofactor, by mimicking a C-like mo-
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12Figure 2. Schematic Representation of the Three-Dimensional X-Ray Structure of the G-Riboswitch Complexed with Hypoxanthine
Schematic representation of the three-dimensional X-ray structure of the G-riboswitch complexed with hypoxanthine [1]. The drawing re-
spects the stacking patterns and illustrates the base edges in contact [17]. A white rectangle indicates in which environment a given base
stacks [18]. Minor differences in the base sequence of the helices exist between the three structures [1, 2]. In the middle box, the contacts
occurring with the other cofactors are shown following the C to U mutation [2, 4]. It is the pyrimidine interacting with the Watson-Crick edge
of the purine cofactor which upon mutation (C to U) changes the purine specificity from G to A. The lower box shows schematic representa-
tions illustrating the mimicry between a C-like motif present in helix h28 of the 16S rRNA [13, 19] (at the right) and the purine binding site of
the riboswitch [1] (at the left). The riboswitch is made of three strands instead of two as in the h28 internal loop. Two pyrimidines form
identical contacts with two consecutive bases engaged in standard Watson-Crick pairs. The R-Y74 Watson-Crick contact is equivalent to the
first Watson-Crick pair of the C-like motif. The rotation angles between those first base pairs and the last ones are around 90°.tif, manages to replace the more frequent and stable A
double A-minor contacts between the pseudo-loop J23 I
and the top of helix P1. The mimicry with the C-like U
motifs is structurally surprising (Figure 2): the rotation U
angle between the first and the last Watson-Crick pairs 1
of the motif is around 90°, and a similar angle is ob- F
served between the equivalent R-Y74 pair and the U20- F
A76 pair of the riboswitch.
RNA molecules experience a vast range of alternative
Sconformations, extending from a single bulged base
occupying various positions within the helical grooves
to rearrangements of the secondary and tertiary struc-
tures. Riboswitches belong to that class of switchable
natural RNA structures [14] which experience a dy-
namic equilibrium with a definite biological function as-
signed to it. The first structures of riboswitches repre-
sent a major advance toward our understanding of how
RNA switches function at the molecular level. This
structural knowledge will strengthen the recent pro-
gress achieved in molecular engineering of synthetic
RNA switches [15] and nanotechnology based on
tectoRNA building blocks [16].urélie Lescoute and Eric Westhof
nstitut de Biologie Moléculaire et Cellulaire
PR9002 du CNRS
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